News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,606 Results
Type
Article (86632)
Company Profile (703)
Press Release (762269)
Multimedia
Podcasts (135)
Webinars (17)
Section
Business (232738)
Career Advice (4129)
Deals (39732)
Drug Delivery (129)
Drug Development (91023)
Employer Resources (198)
FDA (18136)
Job Trends (17348)
News (396603)
Policy (39777)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (97)
Alliances (56895)
ALS (109)
Alzheimer's disease (1528)
Antibody-drug conjugate (ADC) (173)
Approvals (18086)
Artificial intelligence (356)
Autoimmune disease (32)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (121)
Biotechnology (481)
Bladder cancer (91)
Brain cancer (35)
Breast cancer (344)
Cancer (2706)
Cardiovascular disease (225)
Career advice (3536)
Career pathing (34)
CAR-T (193)
Cell therapy (535)
Cervical cancer (22)
Clinical research (73754)
Collaboration (985)
Company closure (3)
Compensation (606)
Complete response letters (30)
COVID-19 (2889)
CRISPR (58)
C-suite (296)
Cystic fibrosis (113)
Data (2639)
Decentralized trials (2)
Denatured (47)
Depression (60)
Diabetes (319)
Diagnostics (6948)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (144)
Drug shortages (34)
Duchenne muscular dystrophy (115)
Earnings (97393)
Editorial (47)
Employer branding (25)
Employer resources (168)
Events (130909)
Executive appointments (846)
FDA (19674)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (897)
Gene editing (135)
Generative AI (36)
Gene therapy (401)
GLP-1 (876)
Government (5195)
Grass and pollen (6)
Guidances (179)
Healthcare (20903)
Huntington's disease (27)
IgA nephropathy (33)
Immunology and inflammation (163)
Immuno-oncology (3)
Indications (32)
Infectious disease (3057)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (110)
Interviews (813)
IPO (17865)
IRA (52)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (13)
Labor market (50)
Layoffs (576)
Leadership (25)
Legal (10124)
Liver cancer (82)
Lung cancer (387)
Lymphoma (185)
Machine learning (9)
Management (65)
Manufacturing (394)
MASH (90)
Medical device (14669)
Medtech (14674)
Mergers & acquisitions (22495)
Metabolic disorders (851)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (127)
Neuropsychiatric disorders (37)
Neuroscience (2199)
NextGen: Class of 2025 (7685)
Non-profit (5086)
Now hiring (44)
Obesity (449)
Opinion (281)
Ovarian cancer (88)
Pain (108)
Pancreatic cancer (96)
Parkinson's disease (178)
Partnered (25)
Patents (275)
Patient recruitment (131)
Peanut (52)
People (65478)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22771)
Phase II (32034)
Phase III (24106)
Pipeline (1561)
Policy (199)
Postmarket research (3552)
Preclinical (10285)
Press Release (72)
Prostate cancer (128)
Psychedelics (39)
Radiopharmaceuticals (275)
Rare diseases (471)
Real estate (7396)
Recruiting (75)
Regulatory (26920)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (8)
RNA editing (9)
RSV (51)
Schizophrenia (88)
Series A (155)
Series B (105)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (78)
Tariffs (61)
The Weekly (86)
Vaccines (845)
Venture capitalists (48)
Weight loss (310)
Women's health (44)
Worklife (20)
Date
Today (1)
Last 7 days (647)
Last 30 days (3341)
Last 365 days (35025)
2025 (15145)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (66)
Alaska (7)
Arizona (275)
Arkansas (14)
Asia (50298)
Australia (8848)
California (7187)
Canada (2239)
China (627)
Colorado (308)
Connecticut (323)
Delaware (179)
Europe (115427)
Florida (1053)
Georgia (246)
Hawaii (1)
Idaho (65)
Illinois (688)
India (31)
Indiana (361)
Iowa (15)
Japan (197)
Kansas (115)
Kentucky (30)
Louisiana (16)
Maine (72)
Maryland (1038)
Massachusetts (5501)
Michigan (262)
Minnesota (453)
Mississippi (3)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (76)
New Hampshire (72)
New Jersey (2005)
New Mexico (31)
New York (2020)
North Carolina (1194)
North Dakota (10)
Northern California (3101)
Ohio (237)
Oklahoma (16)
Oregon (48)
Pennsylvania (1550)
Puerto Rico (17)
Rhode Island (38)
South America (1653)
South Carolina (31)
South Dakota (1)
Southern California (2649)
Tennessee (118)
Texas (1081)
United States (27258)
Utah (210)
Virginia (193)
Washington D.C. (77)
Washington State (647)
West Virginia (4)
Wisconsin (80)
There are 849,606 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Jazz Is in the “Goldilocks Zone” With New Cancer Data at ASCO25
The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through Jazz Pharmaceuticals’ dealmaking over the last five years.
May 31, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001
May 30, 2025
·
4 min read
Press Releases
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
May 30, 2025
·
10 min read
Press Releases
New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology
May 30, 2025
·
13 min read
Press Releases
Clinical Trials Demonstrate Monitoring PD-L1 Upregulation Using LifeTracDx Blood Test Could Support New Treatment Path for Metastatic Triple Negative Breast Cancer
May 30, 2025
·
2 min read
Press Releases
Riboscience Announces Successful Completion of Phase 1a Dose Escalation for RBS2418, a New Anti-Cancer Immunotherapy
May 30, 2025
·
3 min read
Press Releases
NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association
May 30, 2025
·
13 min read
Press Releases
Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision Medicine to Immunotherapy at RNA Society’s 30th Annual Meeting
May 30, 2025
·
3 min read
Press Releases
Faron Announces Publication of Full Phase I BEXMAB Study Data in Lancet Haematology
May 30, 2025
·
6 min read
Press Releases
AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
May 30, 2025
·
3 min read
1 of 84,961
Next
